Affective disorders are a group of mental health conditions that cause significant disruptions in a person’s emotional state, primarily affecting mood, energy levels, and daily functioning. The two main types—depression and bipolar disorder—can be managed effectively with a combination of medication, psychotherapy, and lifestyle changes.

Understanding How Treatment Works for Affective Disorders

The main goal when treating affective disorders is to help people regain control over their emotional states and return to a better quality of life. Treatment approaches vary depending on the specific type of disorder someone has, the severity of their symptoms, and their individual characteristics and health history. For many people living with affective disorders, finding the right treatment combination can dramatically reduce symptoms and prevent future episodes from occurring.^[1]

Medical professionals recognize that affective disorders are chronic conditions requiring ongoing care. This means that even when symptoms improve, treatment typically continues to prevent relapse. The approach to treatment has evolved significantly over the years, moving from simply trying to reduce symptoms to focusing on comprehensive care that addresses all aspects of a person’s life—from their brain chemistry to their daily routines and relationships.^[2]

Standard treatments approved by medical societies form the foundation of care, but researchers continue to explore new therapies through clinical trials. These investigations aim to find treatments that work faster, have fewer side effects, or help people who haven’t responded well to existing options. Understanding both established and emerging treatments helps patients and their families make informed decisions about care.^[4]

Standard Treatment Approaches for Affective Disorders

The cornerstone of treating affective disorders involves a combination of medication and psychotherapy (also called talk therapy). This dual approach addresses both the biological and psychological aspects of these conditions. For depression, healthcare providers often prescribe antidepressants, which are medications designed to correct chemical imbalances in the brain that affect mood and emotions.^[9]

The most commonly prescribed antidepressants belong to a class called selective serotonin reuptake inhibitors or SSRIs. These medications work by increasing the amount of serotonin—a brain chemical that helps regulate mood—available in the spaces between nerve cells. Popular SSRIs help improve mood, reduce anxiety, and restore normal sleep and appetite patterns. However, patients should know that these medications typically take four to six weeks to reach their full effectiveness, so patience during the initial treatment period is important.^[12]

For bipolar disorder, treatment is more complex because it must address both the depressive episodes and the elevated mood states called mania or hypomania. The primary medications used are called mood stabilizers, with lithium being one of the oldest and most studied options. Lithium has been used for decades and remains highly effective for preventing both manic and depressive episodes. It requires regular blood tests to monitor levels in the body and check kidney and thyroid function, as long-term use can affect these organs.^[14]

Anticonvulsants, originally developed to treat seizures, are also used as mood stabilizers in bipolar disorder. Valproic acid (also known as Depakote) is particularly effective for treating acute mania—the periods of extremely elevated mood and energy. Studies have shown that combining valproic acid or lithium with certain other medications can provide better control of manic episodes than using any single medication alone.^[14]

Antipsychotic medications have become increasingly important in treating affective disorders, particularly bipolar disorder. Drugs like quetiapine (Seroquel), risperidone (Risperdal), and others can treat both manic episodes and depressive episodes in bipolar disorder. Some of these medications are also approved for use in severe depression that hasn’t responded to antidepressants alone. The advantage of newer antipsychotic medications is that many can be used for both acute treatment of symptoms and long-term maintenance to prevent future episodes.^[14]

Psychotherapy plays an equally vital role in treatment. Cognitive behavioral therapy, or CBT, is one of the most widely studied and effective forms of talk therapy for affective disorders. CBT helps people identify and change negative thought patterns and behaviors that contribute to their depression or mood instability. During CBT sessions, which typically occur weekly over several months, individuals learn practical skills for managing symptoms, solving problems, and preventing relapse.^[9]

Treatment duration varies considerably. For a first episode of major depression, medication is usually continued for at least six to twelve months after symptoms improve. For people with recurrent depression or bipolar disorder, treatment often continues indefinitely because the risk of relapse is high—more than 70% of people with bipolar disorder experience another episode within five years if they stop treatment.^[8]

Side effects are an important consideration with all medications. Common side effects of SSRIs include feeling agitated or shaky, upset stomach, diarrhea or constipation, and sexual problems. Most of these symptoms improve after the first few weeks of treatment. Lithium can cause increased thirst and urination, tremor, weight gain, and requires regular monitoring. Antipsychotic medications may cause weight gain, drowsiness, and metabolic changes affecting blood sugar and cholesterol levels.^[12]

For seasonal affective disorder (SAD), which typically occurs during fall and winter months when daylight hours are shorter, treatment approaches include those used for other types of depression plus an additional option called light therapy. This involves sitting near a special light box that mimics outdoor sunlight for about 30 minutes to an hour each morning. The bright light appears to affect brain chemicals linked to mood and can relieve symptoms within a few days to weeks for most people. Light therapy is generally well-tolerated and causes few side effects.^[11]

In cases where medications and psychotherapy haven’t provided sufficient relief, several other treatment options exist. Electroconvulsive therapy (ECT) involves delivering controlled electrical stimulation to the brain while the person is under anesthesia. Despite its negative portrayal in popular culture, modern ECT is safe and can be highly effective for severe depression, particularly when someone is at immediate risk of suicide. Transcranial magnetic stimulation (TMS) is a newer, non-invasive option that uses magnetic fields to stimulate nerve cells in the brain and can help people who haven’t responded to antidepressants.^[9]

Innovative Treatments Being Tested in Clinical Trials

Research into new treatments for affective disorders is ongoing, with numerous clinical trials investigating novel approaches. These studies are essential for finding better options for people who don’t respond adequately to current treatments or who experience troublesome side effects. Clinical trials progress through several phases, each designed to answer specific questions about a new treatment’s safety and effectiveness.^[5]

Phase I trials focus primarily on safety, testing a new treatment in a small group of people to evaluate what dose is safe and what side effects occur. Phase II trials expand the number of participants and begin to assess whether the treatment actually works—does it improve symptoms better than placebo? Phase III trials are large studies that compare the new treatment directly with standard treatments to determine if it offers advantages. Only treatments that successfully complete all three phases can be approved for general use.^[5]

One innovative area of research involves medications that work through different mechanisms than traditional antidepressants. While most standard antidepressants focus on serotonin, newer experimental treatments target other brain chemical systems. One particularly promising approach involves a medication called esketamine (delivered as a nasal spray under the brand name Spravato), which is related to the anesthetic drug ketamine. Unlike SSRIs that take weeks to work, ketamine-based treatments can reduce depression symptoms within hours or days.^[18]

This rapid action makes ketamine-related treatments especially valuable for people experiencing severe depression with suicidal thoughts, where waiting weeks for a traditional antidepressant to work could be dangerous. The medication works by affecting a different brain chemical called glutamate and appears to help the brain form new connections between nerve cells. Esketamine is typically used in combination with an oral antidepressant and must be administered in a healthcare setting where the patient can be monitored for side effects.^[18]

Researchers are also investigating how the body’s stress response system relates to depression. The hypothalamic-pituitary-adrenal axis, or HPA axis, is the system that controls our response to stress by releasing hormones like cortisol. Studies have found that many people with depression have an overactive HPA axis, producing too much cortisol. This discovery has led to clinical trials testing medications that can normalize this stress response system, representing a completely different approach to treating depression compared to traditional antidepressants.^[8]

For bipolar disorder, clinical trials are exploring new mood stabilizers and antipsychotic medications with improved side effect profiles. One medication called cariprazine (Vraylar) has shown effectiveness in treating both acute bipolar depression and manic episodes, with research suggesting it may cause less weight gain than some older medications. Another drug, lurasidone (Latuda), has been specifically studied for bipolar depression and appears effective when combined with lithium or valproic acid.^[14]

Clinical trials for affective disorders are being conducted at numerous locations worldwide, including major medical centers in the United States, Europe, and other regions. Eligibility for these trials depends on various factors such as the specific type and severity of affective disorder, previous treatments tried, other medical conditions, and age. Many trials seek participants who haven’t responded well to standard treatments, while others compare new medications against existing ones in people newly diagnosed with an affective disorder.^[5]

Preliminary results from some clinical trials have been encouraging. For instance, studies of ketamine-related treatments have demonstrated rapid reduction in depression scores within 24 hours of administration, with effects lasting several days to weeks. Trials of certain new antipsychotic medications for bipolar disorder have shown improvements in depression symptoms with potentially fewer metabolic side effects like weight gain and diabetes risk compared to older medications.^[14]

Another innovative approach being studied involves chronotherapy—treatments that work by adjusting a person’s biological clock and sleep-wake cycle. Since many people with depression and seasonal affective disorder have disruptions in their circadian rhythms (the internal 24-hour clock that regulates sleep, hormone production, and other body functions), techniques like carefully timed light exposure, sleep scheduling, and even temporary sleep deprivation are being tested. Some studies suggest these approaches can produce rapid improvements in mood, though more research is needed to understand how to use them most effectively.^[8]

Researchers are also investigating whether combining certain supplements with standard treatments might improve outcomes. Vitamin D supplementation is being studied for seasonal affective disorder, particularly since many people with SAD have low vitamin D levels due to reduced sun exposure during winter months. While supplements alone aren’t sufficient to treat affective disorders, they may enhance the effectiveness of other treatments in select individuals.^[21]

Most common treatment methods

• Antidepressant medications
  • Selective serotonin reuptake inhibitors (SSRIs) that increase serotonin levels in the brain and typically require four to six weeks to reach full effectiveness
  • Used as first-line treatment for major depression, dysthymia, and seasonal affective disorder
  • Should be continued for at least six to twelve months after symptoms improve for a first episode
  • Common side effects include initial agitation, stomach upset, and sexual problems that often improve over time
• Mood stabilizers
  • Lithium remains highly effective for preventing both manic and depressive episodes in bipolar disorder, though it requires regular blood monitoring
  • Anticonvulsants like valproic acid (Depakote) effectively treat acute mania and help prevent future episodes
  • Combination therapy using lithium or valproic acid with other medications often provides better symptom control than single medications
  • Treatment typically continues indefinitely due to high relapse risk when stopped
• Antipsychotic medications
  • Quetiapine (Seroquel), risperidone (Risperdal), cariprazine (Vraylar), and lurasidone (Latuda) are used for both acute treatment and maintenance
  • Effective for treating manic episodes, bipolar depression, and severe unipolar depression
  • Can be used alone or in combination with mood stabilizers or antidepressants
  • Side effects may include weight gain, drowsiness, and metabolic changes requiring monitoring
• Psychotherapy
  • Cognitive behavioral therapy (CBT) helps identify and change negative thought patterns and behaviors contributing to mood symptoms
  • Typically involves weekly sessions over several months with a trained therapist
  • Family-focused therapy helps improve relationships and provides education about the disorder
  • Should be used alongside medication for best results rather than replacing pharmacological treatment
• Light therapy
  • Special light boxes that mimic outdoor sunlight are used primarily for seasonal affective disorder
  • Involves sitting near the light box for 30 minutes to one hour each morning upon waking
  • Can relieve symptoms within days to weeks and causes few side effects
  • May trigger manic episodes in people with bipolar disorder, so medical supervision is important
• Brain stimulation therapies
  • Electroconvulsive therapy (ECT) delivers controlled electrical stimulation under anesthesia and is highly effective for severe depression
  • Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells non-invasively
  • Particularly useful for treatment-resistant depression when medications haven’t provided relief
  • Ketamine and esketamine treatments provide rapid symptom relief within hours or days